HOME >> MEDICINE >> NEWS
Gene responsible for cerebral venous abnormalities found

Note to editors: A team of French researchers is announcing similar findings in a news release embargoed for 4 p.m. EDT Thursday. Their findings will appear in the next issue of Nature Genetics. Due to the nature of the discovery, editors of Human Molecular Genetics are lifting their embargo.

DURHAM, N.C. - A group of American researchers, led by geneticists at Duke University Medical Center, has found one of the genes known to be responsible for an inherited form of cerebral cavernous malformations, a difficult-to-detect condition that can cause massive brain hemorrhages. The scientists said discovery of a cerebral cavernous malformations (CCM) gene could herald important medical advances for individuals and families with this condition--especially for the Mexican-American community, which appears to show a higher incidence of CCM than other ethnic groups.

"With DNA testing, we can now pick up the mutation in kids who are not showing symptoms and follow them closely," said Douglas A. Marchuk, lead geneticist of the Duke group. AThis is the significance of the discovery. We can now help alleviate a great deal of the fear surrounding this condition by focusing our efforts on those children and adults who are truly at risk."

Initial genetic analysis of the Mexican-American families included in the study revealed evidence of a so-called "founder effect," which suggests most of the families are descended from a common ancestor. Of the 21 Mexican-American families included in the study, 16 had the same genetic mutation. Different mutations in the same gene in other non-Hispanic families were included in the study as well.

Cerebral cavernous mutations are lesions of large, abnormally shaped blood vessels in the brain. People with CCM often suffer from seizures (sometimes misdiagnosed as epilepsy) or recurrent, severe headaches B usually beginning in their 20s or
'"/>

Contact: Tracey Koepke
Koepk002@mc.duke.edu
919-684-4148
Duke University Medical Center
30-Sep-1999


Page: 1 2 3

Related medicine news :

1. Failure to count Iraqi casualties is irresponsible, say experts
2. Radon in the home responsible for 9% of lung cancer deaths across Europe
3. Gene mutations responsible for childhood cataracts discovered
4. Advances in understanding brain circuits responsible for tics in Tourettes shed light on disorder
5. No significant genetic difference in viruses responsible for two major Hong Kong SARS outbreaks
6. New studies show factors responsible for enhanced response to music
7. Visceral fat loss after dieting is not necessarily responsible for disease risk improvements
8. More frequent ivermectin treatment could reduce symptoms of disease responsible for river blindness
9. MRI superior to ultrasound in predicting cerebral palsy in preterm infants
10. Fetal heart monitoring ineffective at diagnosing cerebral palsy
11. New guidelines for cerebral palsy recommend early neuroimaging tests

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/27/2017)... ... ... Team Novo Nordisk, the world’s first all-diabetes professional cycling team, is bringing Isle ... the remainder of the 2017 season. One of our best development riders, Brand is ... , “Every season we are excited to move an athlete from our pipeline up ...
(Date:7/26/2017)... (PRWEB) , ... July 26, 2017 , ... Capillus, LLC ... treat hereditary hair loss. The new Flexible Fitting Design offers a more comfortable, adaptable ... LLC is delighted with the improvements to the home-use laser therapy caps intended to ...
(Date:7/26/2017)... ... July 26, 2017 , ... A major challenge many labs face is ... samples and a lengthy freeze dry cycle are a few common challenges that can ... as well as new accessories and advancements in laboratory freeze dryers that will improve ...
(Date:7/26/2017)... ... 2017 , ... It's time to sign up for the new One-A-Month Essential Oil ... Heshelow, founder of Sublime Naturals and author of numerous books on essential oils. , ... by the 5th. , Two items are included in the December mailing. ...
(Date:7/26/2017)... Jupiter, Florida (PRWEB) , ... July 26, 2017 ... ... care for dogs and cats has opened in Jupiter. The state of ... patients (cardiology) and class leading treatments with a goal of providing heart patients ...
Breaking Medicine News(10 mins):
(Date:7/26/2017)... 2017 Sancilio Pharmaceuticals Company, Inc. (SPCI) today ... evaluating Altemia TM , an oral therapy for pediatric ... Disease (SCD). The SCOT Trial, is a double-blind, placebo-controlled, ... of Altemia TM in pediatric patients aged 5-17 ... 125274. "The completion ...
(Date:7/24/2017)... Mich. , July 24, 2017  Diplomat Pharmacy, ... it will release its second quarter 2017 operating results ... a conference call to follow at 5:00 p.m. ET. ... participants may listen to a live broadcast of the ... callers, and referencing participant code 51641230 approximately 15 minutes ...
(Date:7/20/2017)... , July 20, 2017  Prime Therapeutics LLC (Prime) released ... , M.D., following today,s Institute for Clinical and Economic Review,s ... on the effectiveness and value of abuse-deterrent formulations (ADF) of ... policy roundtable at the meeting. ... material cost benefit to the use of abuse-deterrent formulations (ADF) ...
Breaking Medicine Technology:
Cached News: